MedPath

Cancer survival of male BRCA mutation carriers: systematic review and meta-analysis

Not Applicable
Conditions
male breast cancer, prostate cancer, pancreatic cancer, colon cancer
Registration Number
JPRN-UMIN000044600
Lead Sponsor
Hiroshima Asa city Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Review articles, case reports, commentaries, published conference abstracts, and letters were excluded.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparing the prognosis of male breast cancer, prostate cancer, pancreatic cancer, and colorectal cancer in male BRCA1 / 2 mutant carriers with non-mutant individuals
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath